Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) and related topics, and indicates recruitment is closed with 'No longer looking for participants'. It also shows a formatting change for the Intervention/Treatment heading and a new revision note (Revision: v3.6.0).SummaryDifference0.5%

- Check20 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, signaling a minor update to the page version.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.5.4 was added. Related topics entries including Melanoma and MedlinePlus Genetics were removed from the related topics section.SummaryDifference0.2%

- Check48 days agoChange DetectedMelanoma is added as a related topic and MedlinePlus Genetics is listed under related topics to provide quick access to disease-specific and genetics resources.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now displays Revision: v3.5.3, replacing Revision: v3.5.2. This represents a small build update to the page and does not alter study details or user-facing content.SummaryDifference0.0%

- Check62 days agoChange DetectedRemoved the small related-topics section for “Melanoma” (including “MedlinePlus Genetics”) from the page.SummaryDifference0.1%

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.